Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership
HB 427 extends the deadline for the Task Force on Responsible Use of Natural Psychedelic Substances to complete its work. The bill modifies existing law (Chapter 793 of the 2024 Acts) to delay the Task Force's report submission date from July 31, 2025, to a new date specified in the bill. This procedural extension affects the Task Force members (including state health officials, university representatives, and community experts) and the Maryland General Assembly, which will receive the final report. The Task Force's duties remain unchanged: studying psychedelic substances like psilocybin, making recommendations for legal access programs, and addressing criminal justice impacts.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2026
Committee Review
Apr 2026
House of Delegates Passage
Apr 2026
Senate Passage
Apr 2026
Signed into Law
Apr 2026
Introduced Jan 22, 2026
Signed Apr 28, 2026
Maddy AI version diff · 2 comparisons
What changed between versions
Third - Task Force on Responsible Use of Natural Psychedelic Substances - Extension
→
Enrolled - Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership
·
2 edits
·
Apr 28, 2026
MINOR
The bill was finalized as an Enrolled Bill, adding a new requirement for a representative from a historically Black college or university to the Task Force. The text was cleaned of internal markup symbols and formatting artifacts from the legislative process.
Scope change
The scope of the Task Force membership was expanded to include a specific representative from a historically Black college or university.
REQUIREMENT
Added a new requirement for the Task Force to include one representative of a historically Black college or university in the State.
TECHNICAL
Removed internal legislative markup symbols (e.g., J1, 6lr2063) and updated the header to reflect the bill's final Enrolled status.
Floor votes · Senate Mar 21, 2026 · House of Delegates Mar 25, 2026
How they voted
43–0
Passed · 6 other
Total votes 49
Mar 21, 2026
D
Democratic36
83% Yea
R
Republican13
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
19
Key actions
11
Committee
6
Amendments
1
Apr 28, 2026
Signed into law
Approved by the Governor - Chapter 207
executive
Apr 10, 2026
Lower · Passed
Passed Enrolled
lower
Apr 10, 2026
Lower · Passed
Third Reading Passed
lower
Apr 10, 2026
Introduced
House Concurs Senate Amendments
lower
Apr 9, 2026
Upper · Passed
Third Reading Passed
upper
Apr 8, 2026
Upper · Passed
Favorable with Amendments {
upper
Apr 8, 2026
Upper · Passed
Favorable with Amendments Report by Finance
upper
Mar 25, 2026
House Of Delegates · Passed
House of Delegates Vote: pass (105-29-8)
house of delegates
Mar 21, 2026
Senate · Passed
Senate Vote: pass (43-0-6)
senate
Feb 20, 2026
Committee
Referred Finance
upper
Feb 19, 2026
Lower · Passed
Third Reading Passed
lower
Feb 17, 2026
Lower · Passed
Favorable Adopted
lower
Feb 16, 2026
Lower · Passed
Favorable Report by Health
lower
Jan 22, 2026
Committee
First Reading Health
lower
10 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 427
Scope: MD
Hi! I can help you understand HB 427. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline